Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications

Front Microbiol. 2022 Mar 24:13:869059. doi: 10.3389/fmicb.2022.869059. eCollection 2022.

Qiwei Zhang^{1

2}, Yiqiang Li¹, Pascal Fender³, Bin Yu⁴, Liqiang Feng⁵, Ling Chen^{5

6}, Xianghui Yu^{4

7}

¹ Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, China.
² Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
³ Institut de Biologie Structurale (IBS), Université Grenoble Alpes, CNRS, CEA, Grenoble, France.
⁴ National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.
⁵ Guangdong Laboratory of Computational Biomedicine, Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences, Guangzhou, China.
⁶ State Key Laboratories of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
⁷ Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, School of Life Sciences, Jilin University, Changchun, China.

No abstract available

Keywords: adenoviral vector; adenovirus; gene therapy; immunity; infection.

Publication types